By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
BAH's Q1 results show a divergence between GAAP and adjusted metrics, with adjusted EPS and EBITDA up while revenue declined. The FY27 guidance implies solid EPS growth but modest revenue growth, and the 11x forward multiple is debated as cheap or fair depending on the sustainability of margin expansion.
Risk: The 4.2% revenue decline and potential contract timing issues or cooling in federal procurement cycles, as well as the risk of sequestration returning in 2026.
Opportunity: The potential for margin expansion through a shift in the backlog toward high-margin software and cyber-integration, as well as the attractive dividend yield.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
(RTTNews) - Booz Allen Hamilton Holding Corporation (BAH), the parent company of advanced technology company Booz Allen Hamilton Inc., on friday, reported first quarter net income of $198 million, a 26.9 percent decrease from a year ago. Earnings per share was $1.63 compared to $2.16. Adjusted net income was $217 million, up 17.9 percent from last year. Adjusted EBITDA was $334 million, up 7.4 percent. Adjusted EPS was $1.81, a 22.3 percent increase from prior year. Revenue was $2.8 billion, a decrease of 4.2 percent year-over-year. Revenue ex-billables was $2.0 billion, down 3.8 percent from last year.
For fiscal 2027, the company expects: revenue of $11.2 - $11.7 billion, and adjusted EPS of $6.00 - $6.35. A regular quarterly dividend of $0.59 per share will be payable on August 28, 2026, to stockholders of record on August 14, 2026.
"Booz Allen is on track with the expectations we set for the fiscal year amid challenging market dynamics," said Horacio Rozanski, Booz Allen Chairman and CEO.
In pre-market trading on NYSE, Booz Allen Hamilton shares are up 2.69 percent to $67.60.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"BAH's adjusted growth and modest valuation offset headline revenue and GAAP declines, leaving the stock fairly valued pending clearer federal budget visibility."
BAH's Q1 headline numbers look ugly: revenue -4.2% to $2.8B, GAAP net income -27% to $198M, EPS $1.63. Yet adjusted EPS rose 22% to $1.81, adjusted EBITDA +7.4%, and the stock is up 2.7% pre-market to $67.60. FY27 guidance implies roughly 5-6% top-line CAGR and mid-teens adjusted EPS growth, which at current levels prices BAH at ~10.5-11x forward adjusted earnings. The defense consulting giant is navigating federal budget uncertainty and slower commercial demand, but its adjusted metrics and dividend commitment suggest operational resilience.
The multi-year revenue decline and sharply lower GAAP earnings could signal deeper contract losses or margin pressure that adjusted figures are masking; if federal spending sequestration returns or commercial wins fail to materialize, the modest FY27 guide may prove optimistic and force multiple compression from already low teens.
"BAH is successfully trading top-line growth for margin expansion, but the long-term thesis hinges on whether the FY27 guidance accounts for a potential slowdown in federal defense spending."
BAH’s Q1 results present a classic divergence between GAAP net income and operational performance. While the 26.9% decline in net income looks alarming, the 22.3% growth in adjusted EPS and a 7.4% rise in adjusted EBITDA suggest the underlying business remains healthy, likely absorbing one-time costs or accounting shifts. The market is clearly focusing on the FY27 guidance of $6.00-$6.35 in adjusted EPS, which implies a solid compounding trajectory. However, the 4.2% revenue decline is a red flag, signaling potential contract timing issues or a cooling in federal procurement cycles. Investors are betting that the margin expansion is sustainable despite the top-line contraction.
The revenue decline could indicate a loss of competitive positioning in high-margin government tech work, making the adjusted EPS growth unsustainable if the firm cannot replace shrinking contract backlogs.
"BAH's adjusted profitability growth masks top-line contraction that FY27 guidance doesn't adequately explain, leaving visibility into whether this is cyclical or structural unclear."
BAH's headline GAAP EPS collapse (−26.9%) masks a more complex story. Adjusted EPS +22.3% and adjusted EBITDA +7.4% suggest operational momentum, but revenue declined 4.2% YoY—a red flag for a defense contractor. The FY27 guidance ($6.00–$6.35 adjusted EPS) implies ~7–8% growth from normalized run-rate, modest for a high-multiple defense play. The dividend increase ($0.59/share) signals confidence, but the pre-market pop (+2.69%) appears modest given the adjusted earnings beat. The real tension: are billable headcount reductions temporary (market adjustment) or structural (demand weakness in core contracts)?
If revenue ex-billables fell 3.8%, that's not temporary staffing normalization—it suggests underlying contract softness or customer budget constraints that adjusted metrics are papering over. FY27 guidance at the low end of range could signal management uncertainty.
"Booz Allen's near-term revenue weakness clashes with optimistic 2027 guidance, making the stock contingent on federal budget stability and execution optimism."
Q1 shows a bifurcated picture: GAAP net income down 26.9% y/y to $198M, while adjusted metrics rise (adjusted EPS +22.3%, EBITDA +7.4%). Revenue fell 4.2% to $2.8B, with revenue ex-billables down 3.8%, signaling sensitivity to mix and potential project delays. The 2027 guidance ($11.2-11.7B revenue; adj EPS $6.00-6.35) implies meaningful margin leverage and growth under further Fed/contract awards, but the gap between GAAP weakness and upbeat longer-range targets warrants caution about utilization, labor costs, and federal budget volatility. The dividend remains attractive (~3.5% yield at $67.60 stock), yet investors should demand cash-flow and backlog clarity before assuming continuation.
However, the strongest counterview is that the Q1 GAAP weakness could reflect deeper top-line fragility if federal budgets tighten or project awards slow. Relying on 2027 targets may mask near-term execution risk and margin pressure from rising talent costs.
"BAH's low-single-digit revenue trajectory through 2027 reflects structural demand weakness that adjusted metrics obscure."
Claude's billable-headcount focus misses the bigger picture: the 3.8% ex-billables drop plus multi-year revenue CAGR guidance of only 5-6% through FY27 signals chronic contract erosion that no amount of adjusted-EBITDA magic can offset. If sequestration returns in 2026, the modest EPS guide collapses. The 11x multiple is not cheap—it's priced for permanent stagnation.
"The revenue decline is a strategic pivot to higher-margin work, not evidence of structural contract erosion."
Grok, your 'stagnation' thesis ignores the massive shift in BAH's backlog toward high-margin software and cyber-integration. The revenue decline isn't 'erosion'; it's a deliberate pivot away from low-margin, pass-through staffing toward proprietary tech implementation. While others fixate on the top-line contraction, they miss the margin expansion potential inherent in this shift. If BAH successfully executes this transition, the 11x multiple is a glaring mispricing, not a reflection of terminal decline.
"The margin-expansion story requires proof of deliberate high-margin contract mix shift; revenue decline alone doesn't confirm it."
Gemini's backlog-pivot thesis is plausible but unverified by the article. The 3.8% ex-billables decline could signal margin-accretive mix shift—or it could signal customers deferring discretionary tech spend amid budget uncertainty. Neither panelist has cited actual backlog composition, contract wins/losses, or customer commentary. Without that, we're guessing whether the revenue drop is strategic repositioning or demand weakness. That distinction determines whether 11x is cheap or fair.
"Backlog details are essential; without them, a 'software pivot' risks being a buzzword, and the ex-billables decline could portend structural demand weakness that 11x is not pricing in."
Gemini's backlog-pivot thesis hinges on details the article doesn't provide. The 3.8% ex-billables decline could be a temporary mix shift or deferment, not a sustainable margin engine. Without backlog composition, contract wins, or customer commentary, the implied 11x multiple looks fragile if near-term awards stall. A pivot-only narrative ignores execution risk and talent-cost dynamics that could erode leverage before FY27 targets materialize.
BAH's Q1 results show a divergence between GAAP and adjusted metrics, with adjusted EPS and EBITDA up while revenue declined. The FY27 guidance implies solid EPS growth but modest revenue growth, and the 11x forward multiple is debated as cheap or fair depending on the sustainability of margin expansion.
The potential for margin expansion through a shift in the backlog toward high-margin software and cyber-integration, as well as the attractive dividend yield.
The 4.2% revenue decline and potential contract timing issues or cooling in federal procurement cycles, as well as the risk of sequestration returning in 2026.